Allopregnanolone

Overview

Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is a neurosteroid metabolite of progesterone that is the most potent endogenous positive allosteric modulator of GABA-A receptors. It is central to the pathophysiology of PMDD and postpartum depression — conditions where abnormal sensitivity to allopregnanolone fluctuations drives mood dysregulation.

PMDD and PPD

  • In PMDD, patients have paradoxical sensitivity to allopregnanolone — normal luteal phase rises in allopregnanolone trigger anxiety and dysphoria rather than the expected anxiolytic/sedative effect [1] [2].
  • Brexanolone (IV allopregnanolone) is FDA-approved for postpartum depression; zuranolone (oral) extends this to MDD [3].
  • Postpartum depression correlates with the precipitous drop in allopregnanolone at delivery [4].

Microbiome Connection

  • The gut microbiome modulates steroid hormone metabolism including progesterone→allopregnanolone conversion.
  • GABA-producing bacteria (Lactobacillus, Bifidobacterium) interact with the GABAergic system that allopregnanolone modulates — a microbiome-neurosteroid-neurotransmitter axis.
  • Dysbiosis-driven inflammation (elevated IL-6, TNF-alpha) alters neurosteroid synthesis enzyme expression.

Cross-References

  • gaba — allopregnanolone modulates GABA-A receptors
  • serotonin — complementary neuroactive pathway in PMDD/PPD
  • estrobolome — steroid hormone metabolism by gut bacteria
  • gut brain axis — neurosteroid signaling

References (5)

  1. Qian Gao, Wei Sun, Yue-Rui Wang et al. (2023). Gao 2023 — Allopregnanolone-GABA_A Receptor Sensitivity in PMDD Pathogenesis. Frontiers in Psychiatry. doi:10.3389/fpsyt.2023.1140796
  2. Khalida Itriyeva (2022). Itriyeva 2022 — PMS and PMDD in Adolescents (Review). Current Problems in Pediatric and Adolescent Health Care. doi:10.1016/j.cppeds.2022.101187
  3. Inger Sundström-Poromaa, Erika Comasco (2023). Sundström-Poromaa 2023 — New Pharmacological Approaches to PMDD Management. CNS Drugs. doi:10.1007/s40263-023-01004-9
  4. Om Suryawanshi, Sandhya Pajai (2022). Suryawanshi 2022 — A Comprehensive Review on Postpartum Depression. Cureus. doi:10.7759/cureus.32745
  5. Bo Liu, Guangbin Wang, Dongmei Gao et al. (2014). Liu 2014 — GABA and Glutamate-Glutamine Alterations in PMDD (3T MRS). Psychiatry Research: Neuroimaging. doi:10.1016/j.pscychresns.2014.10.020

Related Articles